Drug intelligence / Profile preview

atractylenolide III

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Atractylenolide III is a sesquiterpenoid lactone and one of the main bioactive constituents derived from plants such as Atractylodes macrocephala and Codonopsis pilosula, commonly used in traditional Chinese medicine. It exhibits various biological activities, including anti-oxidant, anti-tumor, anti-inflammatory, anti-allergic, anti-bacterial, and neuroprotective effects. Mechanistically, it has been reported to activate the adiponectin receptor 1 (AdipoR1)-mediated AMPK/SIRT1 signaling pathway, leading to improved lipid metabolism and reduced oxidative stress, inflammation, and fibrosis. In cancer models, it inhibits Jak3/Stat3-dependent IDO expression, Stat3 nuclear translocation, and fibroblast growth factor receptors FGFR1, FGFR2, and FGFR4, thereby exhibiting immune modulatory and anti-neoplastic activities[1][3][5]. There are no records of commercial pharmaceutical products, and its use is currently confined to research and as a natural product in traditional medicines.

Other names
atractylenolide IIIcodonolactone73030-71-4HSDB 8108HSDB8108HSDB-8108ICodonolactoneAtractylenolide βLeucolactone IIIatractylenolide-3atractylenolide3atractylenolide 3atracylenolide III8-hydroxyasterolideatractylenolide III USP/EP/BP
02

Targets

JAK3 (Janus kinase 3)ADIPOR1 (Adiponectin receptor 1)

Beyond the preview

Go deeper on atractylenolide III.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on atractylenolide III.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call